# A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

> **NCT00545272** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 392 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** indacaterol
- **DRUG:** formoterol
- **DRUG:** placebo to indacaterol
- **DRUG:** placebo to formoterol
- **DRUG:** short acting β2-agonist

## Key facts

- **NCT ID:** NCT00545272
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2013-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545272, "A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00545272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*